Estrogen Receptor–Negative Invasive Breast Cancer: Imaging Features of Tumors with and without Human Epidermal Growth Factor Receptor Type 2 Overexpression

Growth Factor ◽

Growth Factor Receptor ◽

Imaging Features ◽

Breast Cancer Imaging ◽

Epidermal Growth ◽

Estrogen Receptor Negative

Tumor biology in estrogen receptor-positive, human epidermal growth factor receptor type 2-negative breast cancer: Mind the menopausal status

World Journal of Clinical Oncology ◽

10.5306/wjco.v6.i6.220 ◽

2015 ◽

Vol 6 (6) ◽

pp. 220 ◽

Cited By ~ 5

Author(s):

Hiroko Yamashita

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Menopausal Status ◽

Tumor Biology ◽

Growth Factor Receptor ◽

Estrogen Receptor Positive ◽

Keratin 17 is overexpressed and predicts poor survival in estrogen receptor–negative/human epidermal growth factor receptor-2–negative breast cancer

Human Pathology ◽

10.1016/j.humpath.2016.10.006 ◽

2017 ◽

Vol 62 ◽

pp. 23-32 ◽

Cited By ~ 12

Author(s):

Ross D. Merkin ◽

Elizabeth A. Vanner ◽

Jamie L. Romeiser ◽

A. Laurie W. Shroyer ◽

Luisa F. Escobar-Hoyos ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Poor Survival ◽

Epidermal Growth ◽

Keratin 17 ◽

Estrogen Receptor Negative

Combined paclitaxel and cetuximab achieved a major response on the skin metastases of a patient with epidermal growth factor receptor-positive, estrogen receptor-negative, progesterone receptor-negative and human epidermal growth factor receptor-2-negative (triple-negative) breast cancer

Anti-Cancer Drugs ◽

10.1097/cad.0b013e3280adc8e0 ◽

2007 ◽

Vol 18 (7) ◽

pp. 835-837 ◽

Cited By ~ 25

Author(s):

Dany Gholam ◽

Amale Chebib ◽

Dominique Hauteville ◽

Marie-Pierre Bralet ◽

Claude Jasmin

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Triple Negative ◽

Growth Factor Receptor ◽

Major Response ◽

Epidermal Growth ◽

Estrogen Receptor Negative

Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Testing in Breast Cancer

Applied Immunohistochemistry & Molecular Morphology ◽

10.1097/pai.0000000000000525 ◽

2019 ◽

Vol 27 (1) ◽

pp. 1-7 ◽

Cited By ~ 1

Author(s):

Nosaibah Hariri ◽

Farnaz Hasteh ◽

Vighnesh Walavalkar ◽

Andres A. Roma ◽

Oluwole Fadare

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer

International Journal of General Medicine ◽

10.2147/ijgm.s314055 ◽

2021 ◽

Vol Volume 14 ◽

pp. 2777-2783

Author(s):

Gulijire Tailaiti ◽

Gulanbaier Maimaiti ◽

Youlituzi Aikeremu ◽

Batuer Tuerdi

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Invasive Breast Cancer ◽

Growth Factor Receptor ◽

X Ray ◽

Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells

Molecular Medicine Reports ◽

10.3892/mmr.2018.8580 ◽

2018 ◽

Cited By ~ 1

Author(s):

Seung Taek Lim ◽

Ye Won Jeon ◽

Hongki Gwak ◽

Se Young Kim ◽

Young Jin Suh

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Breast Cancer Cells ◽

Growth Factor Receptor ◽

Anticancer Effects ◽

Estrogen Receptor Positive ◽

Epidermal Growth ◽

Positive Breast Cancer

Evaluation of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Status Before and After Neoadjuvant Chemotherapy in Breast Cancer Patients

Indian Journal of Surgery ◽

10.1007/s12262-020-02380-y ◽

2020 ◽

Author(s):

Adarsh Verma ◽

Amrita Ghosh Kar ◽

Ram Niwas Meena ◽

S. C. U. Patne ◽

Shashi Prakash Mishra ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Neoadjuvant Chemotherapy ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Before And After ◽

Correlation between microRNA-21, microRNA-206 and estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 in breast cancer

Clinical Biochemistry ◽

10.1016/j.clinbiochem.2019.07.002 ◽

2019 ◽

Vol 71 ◽

pp. 52-57 ◽

Cited By ~ 4

Author(s):

Yuanwen Chen ◽

Nian Wu ◽

Lei Liu ◽

Huaying Dong ◽

Chengyi Wu

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Efficacy and safety of bevacizumab in the treatment of human epidermal growth factor receptor type 2 negative metastatic breast cancer: About a large series in moroccan population

Indian Journal of Cancer ◽

10.4103/0019-509x.146779 ◽

2014 ◽

Vol 51 (3) ◽

pp. 272 ◽

Cited By ~ 1

Author(s):

N Majid ◽

S Boutayeb ◽

H Errihani

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Abstract P3-01-04: DETECT V – Expression analysis of human epidermal growth factor receptor 2 and estrogen receptor on circulating tumor cells of metastatic breast cancer patients

10.1158/1538-7445.sabcs18-p3-01-04 ◽

2019 ◽

Author(s):

T Fehm ◽

F Meier-Stiegen ◽

S Riethdorf ◽

B Rack ◽

F-A Taran ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽